RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Small Cap

-$0.93

EPS Forecast

$187

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.93

Revenue Forecast:

$187

EPS Surprise Forecast:

$0.084

Revenue Surprise Forecast:

$3

Post-release price volatility - Very high

Post-release Overnight Move:

±10.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

63%

Probability of beating revenue consensus:

59%

Probability of beating both EPS & revs consensus:

42%

Probability of missing both EPS & revs consensus:

21%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.00

Earnings volatility

EPS standard deviation:

$0.68

Revenue standard deviation:

$37

As % of share price:

4.44% EXTREME UNCERTAINTY

As % of market cap:

2.48% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.07

Revenue 95th %ile:

$233

EPS 75th %ile:

-$0.70

Revenue 75th %ile:

$199

EPS 25th %ile:

-$1.12

Revenue 25th %ile:

$176

EPS 5th %ile:

-$1.71

Revenue 5th %ile:

$148

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

66% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$14

Bid-ask per Share:

$0.02